A100D (p.Ala100Asp) variant of CDH2 (Cadherin-2)
A100D (p.Ala100Asp) in CDH2 (Cadherin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
A100D (p.Ala100Asp) variant details
- p.Ala100Asp
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.27
- MetaSVM -0.65
- SIFT 0.29
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available